title: Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification.
authors.forename: Kazunari
authors.initials: K
authors.lastname: Aoki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Arima
authors.forename: Sumie
authors.initials: S
authors.lastname: Tabata
authors.forename: Akiko
authors.initials: A
authors.lastname: Matsushita
authors.forename: Takayuki
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Takayuki
authors.initials: T
authors.lastname: Takahashi
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D002555:Cerebrospinal Fluid; D005260:Female; D006801:Humans; D007564:Japan; D007866:Leg; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012074:Remission Induction; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D014944:World Health Organization